Date Filing Filing Description Download
Apr 24, 2019 DEFA14A Additional Proxy Soliciting Materials (definitive)
Apr 24, 2019 DEF 14A Proxy Statement (definitive)
Apr 22, 2019 8-K Current report filing
Apr 10, 2019 4 Statement of Changes in Beneficial Ownership
Apr 10, 2019 3 Initial Statement of Beneficial Ownership
Apr 01, 2019 4 Statement of Changes in Beneficial Ownership
Mar 20, 2019 4 Statement of Changes in Beneficial Ownership
Mar 18, 2019 10-K Annual Report
Mar 15, 2019 8-K Current report filing
Mar 13, 2019 8-K Current report filing
Mar 08, 2019 SC 13G/A Amended Statement of Ownership
Mar 04, 2019 NT 10-K Notification that Annual Report will be submitted late
Feb 28, 2019 8-K Current report filing
Feb 25, 2019 SC 13G Statement of Ownership
Feb 22, 2019 8-K Current report filing
Feb 14, 2019 5 Annual Statement of Changes in Beneficial Ownership
Feb 14, 2019 SC 13G/A Amended Statement of Ownership
Feb 14, 2019 SC 13G Statement of Ownership
Feb 14, 2019 SC 13G/A Amended Statement of Ownership
Feb 14, 2019 SC 13G Statement of Ownership
Feb 12, 2019 SC 13G/A Amended Statement of Ownership
Feb 11, 2019 SC 13G/A Amended Statement of Ownership
Feb 11, 2019 SC 13G/A Amended Statement of Ownership
Jan 28, 2019 SC 13G/A Amended Statement of Ownership
Jan 07, 2019 8-K Current report filing

NYSE: DPLO

-0.10 -1.81% $ 5.41 Volume: 27,144 Common Stock | 20 minute delay April 25, 2019

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now